Stock Chart
FOLD
Type: SELL growth_1yr
Strike: $15
Premium: $0.10
Expiry: Jan 15, 2027
Target: $14
Score: -100
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About FOLD - Amicus Therapeutics, Inc
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The …
Key Statistics
More FOLD Analysis
This FOLD stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track FOLD's price movements with trendlines, gamma walls, and key support/resistance levels.